
Aktis Oncology, Inc.
USD33.73
+3.62 (+12.02%)
CEO
Matthew Roden
IPO Date
2026-01-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$29.63
Prev. Close
$30.11
Day Low
$29.49
Day High
$33.84
52W Low
$14.72
52W High
$33.84
Market Cap
$1.80B
Volume
0.20M
| 7 Sept 2023 |
| Oppenheimer |
| Outperform |
| Outperform |
| maintain |
| 7 Sept 2023 | B. Riley Securities | Buy | Neutral | downgrade |
| 9 May 2023 | Roth MKM | Buy | Buy | maintain |
| 9 May 2023 | Oppenheimer | Outperform | Outperform | maintain |
| 15 Nov 2022 | Oppenheimer | Outperform | Outperform | maintain |
| 13 Sept 2022 | Piper Sandler | Overweight | Overweight | maintain |
| 3 May 2022 | Piper Sandler | Overweight | Overweight | maintain |